Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake

Vaccine

Volumn 30, Issue 49, 2012, Pages 6967-6970

  Donadiki, Elisavet M ^a   Jiménez García, Rodrigo ^b   Hernández Barrera, Valentín ^b   Carrasco Garrido, Pilar ^b   López de Andrés, Ana ^b   Velonakis, Emmanuel G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Department of Preventive Medicine and Public Health and Medical Inmunology and Microbiology ^*  (Spain)

Author keywords

Coverage; Human papillomavirus; Predictors; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CONDOM; CROSS-SECTIONAL STUDY; DRUG COST; DRUG UPTAKE; EDUCATIONAL STATUS; FEMALE; GREECE; GYNECOLOGIST; HEALTH SERVICE; HIGH SCHOOL STUDENT; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; VACCINATION; WART VIRUS;

ADOLESCENT; ADULT; FEMALE; GREECE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; QUESTIONNAIRES; STUDENTS; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84869083617     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.028     Document Type: Article

References (17)

1. Garland S.M., Smith J.S. Human papillomavirus vaccines: current status and future prospects. Drugs 2010, 70(9):1079-1098.
2. Lyimo F.S., Beran T.N. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications. BMC Public Health 2012, 12:22.
3. Vinodhini K., Shanmughapriya S., Das B.C., Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet 2012, 285(3):771-777.
4. CDC FDA licensure of bivalent human papillomavirus vaccine (HPV2, cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59(20):626-629.
5. European Cervical Cancer Association. Available at [accessed 15.08.12]. http://www.ecca.info/fileadmin/user_upload/HPV_Vaccination/ECCA_HPV_Vaccination_April_2009.pdf.
6. Mammas I.N., Vageli D., Spandidos D.A. Geographic variations of human papilloma virus infection and their possible impact on the effectiveness of the vaccination programme. Oncol Rep 2008, 20(1):141-145.
7. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29:890-895.
8. Blödt S., Homberg C., Muller-Nordhorn J., Rieckmann N. Human papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany. Eur J Public Health 2011, December 23 [Epub ahead of print].
9. Mehu-Parant F., Rouzier R., Soulat J-M., Parant O. Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program. Eur J Obstet Gynecol Reprod Biol 2010, 148:186-190.
10. Tiro J.A., Tsui J., Bauer H.M., Yamada E., Kobrin S., Breen N. Uptake and correlatos of the human papillomavirus vaccine hmong adolescents girls and young adult women: an análisis of the 2007 California Health Interview Survey. J Womens Health (Larchmt) 2012, 21(6):656-665.
11. Giambi C., Donati S., Declich S., Salmaso S., Degli Atti M.L., Alibrandi M.P., et al. Estimated acceptance of HPV vaccination among Italian women aged 18-26 years. Vaccine 2011, 29(46):8373-8380.
12. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010, 171(3):357-367.
13. Zimet G.D., Weiss T.W., Rosenthal S.L., Good M.B., Vichnin M.D. Reasons for non-vaccination intentions among 19-26 year-old women. BMC Womens Health 2010, 10:27.
14. Bednarczyk R.A., Birkhead G.S., Morse D.L., Doleyres H., McNutt L.A. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State University, 2010. Vaccine 2011, 29(17):3138-3143.
15. Manhart L.E., Burgess-Hull A.J., Fleming C.B., Bailey J.A., Haggerty K.P., Catalano R.F. HPV vaccination among a community sample of young adult women. Vaccine 2011, 29(32):5238-5244.
16. Hopfer S., Clippard J.R. College women's HPV vaccine decision narratives. Qual Health Res 2011, 21(2):262-277.
17. Patel D.A., Zochowski M., Peterman S., Dempsey A.F., Ernst S., Dalton V.K. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health 2012, 60(2):151-161.